ArticleCureus2025

Long-Term Joint Function and Quality of Life Following Emicizumab Prophylaxis in Severe Hemophilia A: A Single-Center Study From Goa, India.

Ramnath P Nevrekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.